IDRC - International Development Research Centre

Objet publié

The goal of this program under the Clinical Trials Capacity Building component of the Canadian HIV Vaccine Initiative (CHVI) is to strengthen the capacity of researchers and research institutions to conduct high-quality clinical trials, and to build site capacity to undertake clinical trials of HIV vaccines and other preventive technologies, in low- and middle-income countries. The second phase of the project continues to support building sustainable African capacity and leadership to conduct future HIV/AIDS prevention trials, with a special focus on innovations in HIV vaccines trials. The project also seeks to advance the collaboration and networking of African, Canadian, and international researchers and institutions in global HIV/AIDS prevention trials. The project intends to build capacity at multiple levels (individual, team, institution, network, etc.), while emphasizing the need to extend the concept of capacity beyond the traditional technical and scientific skills to include management, leadership, administration, and community and policy engagement.